ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1006

$1.07M Total Retail Price of All Prescriptions

Rank: 36 out of 1006

361 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 12,943 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 650 530 1 1
WARFARIN SODIUM 625 543 2 8
AMLODIPINE BESYLATE 576 514 3 4
RISPERIDONE 380 315 4 40
LISINOPRIL 360 305 5 3
FUROSEMIDE 354 325 6 6
CARVEDILOL 347 314 7 36
METOPROLOL TARTRATE 331 300 8 7
RAMIPRIL 330 256 9 79
OMEPRAZOLE 325 278 10 9
DONEPEZIL HCL 309 308 11 17
ATORVASTATIN CALCIUM 264 238 12 5
METOPROLOL SUCCINATE 261 231 13 12
QUETIAPINE FUMARATE 239 201 14 45
LEVETIRACETAM 237 203 15 72
CITALOPRAM HBR 230 209 16 24
MIRTAZAPINE 224 220 17 26
GABAPENTIN 222 151 18 20
NAMENDA 218 218 19 34
LEVOTHYROXINE SODIUM 214 186 20 2
TRAZODONE HCL 194 191 21 21
LANTUS 188 153 22 43
DIVALPROEX SODIUM 186 183 23 53
TAMSULOSIN HCL 161 150 24 23
DIOVAN 155 146 25 16
GLIPIZIDE 150 144 26 69
TRAMADOL HCL 146 132 27 35
HYDRALAZINE HCL 145 130 28 100
GLIPIZIDE ER 140 92 29 108
POLYETHYLENE GLYCOL 3350 133 99 30 91
HYDROCHLOROTHIAZIDE 124 104 31 11
GENERLAC 118 66 32 140
METFORMIN HCL 116 76 33 10
CLOZAPINE 112 112 34 107
POTASSIUM CHLORIDE 109 82 35 30
SEROQUEL 108 99 36 97
SERTRALINE HCL 107 90 37 19
NOVOLOG 106 99 38 94
PREDNISONE 99 84 39 33
CYMBALTA 99 52 39 41
CLOPIDOGREL 95 86 41 46
BACLOFEN 94 38 42 95
NIASPAN 90 72 43 212
ISOSORBIDE MONONITRATE ER 83 80 44 59
ESCITALOPRAM OXALATE 80 69 45 27
FLUOXETINE HCL 79 71 46 85
LIDODERM 79 76 46 66
GLIPIZIDE XL 79 44 46 175
ATENOLOL 78 74 49 13
HUMALOG 78 71 49 116
CRESTOR 72 58 51 18
OLANZAPINE 72 59 51 68
JANUVIA 72 65 51 49
SPIRIVA 70 61 54 48
ZOLPIDEM TARTRATE 69 47 55 14
PANTOPRAZOLE SODIUM 68 56 56 32
DOXAZOSIN MESYLATE 67 67 57 87
LEVOFLOXACIN 64 58 58 96
PLAVIX 63 62 59 61
ADVAIR DISKUS 63 56 59 37
AMITIZA 61 35 61 181
IPRATROPIUM-ALBUTEROL 60 47 62 73
ALLOPURINOL 60 58 62 31
SANTYL 56 56 64 215
PAROXETINE HCL 55 55 65 62
BENZTROPINE MESYLATE 55 54 R 65 106
NOVOLIN R 54 52 67 158
BRIMONIDINE TARTRATE 54 54 67 245
FINASTERIDE 53 53 69 76
VENLAFAXINE HCL ER 51 38 70 105
FENTANYL 50 44 S2 71 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.